Medical News

Add to Favorites Subscribe Share
newswise-fb-share-
Embargo will expire:
25-Feb-2020 12:00 AM EST
Released to reporters:
21-Feb-2020 6:15 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Feb-2020 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

UTSW_logo.png

Changing what heart cells eat could help them regenerate

UT Southwestern Medical Center

Switching what the powerhouses of heart cells consume for energy could help the heart regenerate when cells die.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Pharmaceuticals,

Released:
21-Feb-2020 4:20 PM EST
Open in New Tab
Comment
Research Results
Newswise: Scientists use neutrons to try to develop better, less costly dental restorations

Scientists use neutrons to try to develop better, less costly dental restorations

Oak Ridge National Laboratory

Teeth damaged by trauma or disease require treatment to look and feel as good as new, but the restorative materials available to dentists don’t always last and can be costly for patients. Researchers from the University of Oklahoma Health Sciences Center's College of Dentistry are using neutrons at ORNL's High Flux Isotope Reactor to change that.

Channels: Biotech, Oral Health, DOE Science News,

Released:
21-Feb-2020 3:35 PM EST
Open in New Tab
Comment
Research Results
Newswise: Lipid signaling from beta cells can potentiate an inflammatory macrophage polarization

Lipid signaling from beta cells can potentiate an inflammatory macrophage polarization

University of Alabama at Birmingham

The insulin-producing beta cells in the pancreas unwittingly produce a signal that may aid their own demise in Type 1 diabetes, according to a study of the lipid signals that drive macrophage cells in the body to two different phenotypes of activated immune cells.

Channels: All Journal News, Diabetes, National Institutes of Health (NIH), Grant Funded News,

Released:
21-Feb-2020 3:05 PM EST
Open in New Tab
Comment
Feature
Newswise: For Weight-Loss Surgery Patients Who Quit Smoking, Relapse is Common
  • Embargo expired:
    21-Feb-2020 3:00 PM EST

For Weight-Loss Surgery Patients Who Quit Smoking, Relapse is Common

Health Sciences at the University of Pittsburgh

Although 1 in 7 adults smoke cigarettes the year prior to undergoing weight-loss surgery, nearly all successfully quit at least a month before their operation. However, smoking prevalence steadily climbs to pre-surgery levels within seven years, according to new research.

Channels: All Journal News, Public Health, Smoking, Surgery, Weight Loss, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant Funded News,

Released:
18-Feb-2020 12:25 PM EST
Open in New Tab
Comment
Research Results
Embargo will expire:
24-Feb-2020 2:00 PM EST
Released to reporters:
21-Feb-2020 1:55 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Feb-2020 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Newswise: New discovery may drive the development of better, more effective immunotherapies for the treatment of breast cancer

New discovery may drive the development of better, more effective immunotherapies for the treatment of breast cancer

University of California, Irvine

New cancer immunotherapy approaches are revolutionizing treatment options for breast cancer patients. However, many lead to insufficient immune responses rendering the therapies incapable of completely eradicating tumors. In a new study, published today in Science Immunology, University of California, Irvine researchers determined the molecular features of certain cells associated with breast cancer, which may open up new avenues into improving cancer immunotherapy.

Channels: All Journal News, Cancer, Healthcare, Women's Health, National Cancer Institute (NCI), National Institutes of Health (NIH), Grant Funded News,

Released:
21-Feb-2020 1:30 PM EST
Open in New Tab
Comment
Research Results
Embargo will expire:
27-Feb-2020 11:00 AM EST
Released to reporters:
21-Feb-2020 1:25 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Feb-2020 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Embargo will expire:
24-Feb-2020 11:00 AM EST
Released to reporters:
21-Feb-2020 12:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Feb-2020 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results


0.99685